Фармакологические аспекты лечения острой гликозидной интоксикации

Фармакологические аспекты лечения острой гликозидной интоксикации

Автор: Шперлинг М.И., Кручинин Е.Г., Гоголевский А.С.

Журнал: Вестник медицинского института "РЕАВИЗ": реабилитация, врач и здоровье @vestnik-reaviz

Рубрика: Клиническая медицина

Статья в выпуске: 4 (52), 2021 года.

Бесплатный доступ

Несмотря на активное внедрение хирургических методов лечения сердечной патологии и новых синтетических кардиотонических средств, сердечные гликозиды (СГ) остаются важной составляющей фармакологической терапии заболеваний сердца. Более того, интерес к данной группе препаратов только возрастает с учетом открытия новых фармакологических эффектов, таких как противоопухолевый и противовирусный. Однако, несмотря на многолетний опыт применения, вопрос ведения пациентов с симптомами как острой, так и хронической интоксикации СГ остается одним из ведущих. В обзоре литературы приводится краткий исторический очерк отравлений сердечными гликозидами, описываются особенности фармакокинетики и фармакодинамики данной группы препаратов. Рассмотрена клиническая картина отравлений СГ. Проанализированы современные представления и ограничения антидотной терапии, а также особенности патогенетического и симптоматического лечения пациентов с острой гликозидной интоксикацией.

Еще

Сердечные гликозиды, гликозидная интоксикация, fab-фрагменты антител к дигоксину

Короткий адрес: https://sciup.org/143177458

IDR: 143177458   |   DOI: 10.20340/vmi-rvz.2021.4.CLIN.1

Список литературы Фармакологические аспекты лечения острой гликозидной интоксикации

  • Withering W. An account on the foxglove, and some of its medical uses with practical remark on dropsy and other diseases. G. G. J. & J. Robinson, London.1785:207. https://doi.org/10.5962/bhl.title.3869
  • Calderón-Montaño J.M., Burgos-Morón E., Orta M.L., Maldonado-Navas D., García-Domínguez I., López-Lázaro M. Evaluating the cancer therapeutic potential of cardiac glycosides. Biomed. Res. Int. 2014:794930. https://doi.org/10.1155/2014/793930
  • Amarelle L, Lecuona E. The Antiviral Effects of Na,K-ATPase Inhibition: A Minireview. Int J Mol Sci. 2018;19 (8):2154. https://doi.org/10.3390/ijms19082154
  • Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27): 2129-2200. https://doi.org/10.1093/eurheartj/ehw128
  • Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, European Heart Journal. 2016;37(38):2893-2962. https://doi.org/10.1093/eurheartj/ehw210
  • Suvorov A.V., Kaurov Ya.V., Suvorov M.A. Features of cardiac arrhythmias and conduction in acute poisoning with cardiotoxic substances. Bulletin of RUDN university, Medicine. 2014;(3):26-30 (in Russ).
  • Supervia Caparros A., Salgado Garcia E., Calpe Perarnau X., Galicia Paredes M., Garcia Gibert L., Cordoba Ruiz F., Clemente Rodríguez C., Nogué Xarau S. Immediate and 30 days mortality in digoxin poisoning cases attended in the Hospital Emergency Services of Catalonia, Spain. Emergencias Rev la Soc Esp Med Emergencias. 2019;31(1):39-42.
  • Gaillard Y., Krishnamoorthy A., Bevalot F. Cerebra odollam: a 'suicide tree' and cause of death in the state of Kerala. JEthnopharmacol. 2004;95(2-3):123-126. https://doi.org/10.1016/j.jep.2004.08.004
  • Eddleston M, Ariaratnam C.A., Meyer W.P., Perera G., Kularatne A.M., Attapattu S., Sheriff M.H., Warrell D.A. Epidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in northern Sri Lanka. Trop Med Int Health. 1999;4(4):266-273. https://doi.org/10.1046/j.1365-3156.1999.00397.x
  • Burchell H.B. Digitalis poisoning: historical and forensic aspects. J Am Coll Cardiol. 1983;1(1):506-516. https://doi.org/10.1016/s0735-1097(83)80080-1
  • Gosudarstvennyj reestr lekarstvennyh sredstv. URL: https://grls.rosminzdrav.ru (in Russ).
  • Kanji S., MacLean R.D. Cardiac glycoside toxicity: more than 200 years and counting. Crit Care Clin. 2012;28(4):527-535. https://doi.org/10.1016Zj.ccc.2012.07.005
  • Morsy N. Cardiac Glycosides in Medicinal Plants. Aromatic and Medicinal Plants - Back to Nature. 2017;(2):29-45. https://doi.org/10.5772/65963
  • Schonfeld W., Weiland J., Lindig C., Masnyk M., Kabat M.M., Kurek A., Wicha J., Repke K.R.H. The lead structure in cardiac glycosides is 5p,14p-androstane-3p14-diol. Naunyn Schmiedebergs Arch. Pharmacol. 1985;329:414-426. https://doi.org/10.1007/BF00496377
  • Brown L., Thomas R., Watson T. Cardiac glycosides with non-rotting steroid to sugar linkages: tools for the study of digitalis structure-activity relationships. Arch. Pharmacol. 1986;332(1):98-102. https://doi.org/10.1007/bf00633205
  • Sousa L.Q., Machado K.D., Oliveira S.F., et al. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na+/K+-ATPase inhibition. Toxicon. 2017;127:63-76. https://doi.org/10.1016/j.toxicon.2017.01.004
  • Ogawa H., Shinoda T., Cornelius F., Toyoshima C. Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci USA. 2009; 106(33): 13742-13747. https://doi.org/10.1073/pnas.0907054106
  • FDA Approved Drug Products: Lanoxin (digoxin) oral tablets, 2015 (revised in 2019). https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020405s015lbl.pdf
  • Dipolo R., Beauge L. Sodium/calcium exchanger: Influence of metabolic regulation on ion carrier interactions. Physiological Reviews journal. 2006;86(1):155-203. https://doi.org/10.1152/physrev.00018.2005
  • Schoner W., Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am J Cardiovasc Drugs. 2007;7(3):173-189. https://doi.org/10.2165/00129784-200707030-00004
  • Gonano L.A., Sepulveda M., Rico Y., Kaetzel M., Valverde C.A., Dedman J., Mattiazzi A., Vila Petroff M. Cal-cium-calmodulin kinase II mediates digitalis-induced arrhythmias. Circ Arrhythm Electrophysiol. 2011;4(6):947-957. https://doi.org/10.1161/CIRCEP.111.964908
  • Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol. 1983;245(1):C1-C14. https://doi.org/10.1152/ajpcell.1983.245.1.C1
  • Yuan Z., Cai T., Tian J., Ivanov A.V., Giovannucci D.R., Xie Z. Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol Cell. 2005;16(9):4034-4045. https://doi.org/10.1091/mbc.e05-04-0295
  • Kamp T.J., Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res. 2000;87(12):1095-1102. https://doi.org/10.1161/01.res.87.12.1095
  • Kushakovskij M.S., Grishkin Yu.N. Arrhythmias of the heart. Heart rhythm and conduction disorder: a guide for doctors. 4th edition. St. Petersburg: Foliant, 2017:720. (in Russ).
  • Levi A.J., Dalton G.R., Hancox J.C., Mitcheson J.S., Issberner J., Bates J.A. Evans S.J., Howarth F.C., Hobai I.A., Jones J.V. Role of intracellular sodium overload in the genesis of cardiac arrhythmias. J Cardiovasc Electrophysiol. 1997;8(6):700-721. https://doi.org/10.1111/j.1540-8167.1997.tb01834.x
  • Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003;289(7):871-878. https://doi.org/10.1001/jama. 289.7.871
  • Bismuth C., Gaultier M., Conso F., Efthymiou M.L. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6(2): 153-162. https://doi.org/10.3109/15563657308990513
  • Bagrov A.Y., Shapiro J. I., Fedorova O.V. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacological reviews. 2009;61(1):9-38. https://doi.org/10.1124/pr.108.000711
  • Yang E.H., Shah S., Criley J.M. Digitalis toxicity: a fading but crucial complication to recognize. Am J Med. 2012;125(4):337-343. https://doi.org/10.1016/j.amjmed.2011.09.019
  • Ito S., Woodland C., Harper P.A., Koren G. P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model. Life Sci. 1993;53(2):PL25-PL31. https://doi.org/ 10.1016/0024-3205(93)90667-R
  • Hanke N., Frechen S., Moj D., Britz H., Eissing T., Wendl T., Lehr T. PBPK models for CYP3A4 and P-gp DDI prediction: a modeling network of rifampicin, itraconazole, clarithromycin, midazolam, alfentanil, and digoxin. CPTPharmacometrics Syst Pharmacol. 2018;7(10):647-659. https://doi.org/10.1002/psp4.12343
  • Roberts D.M., Buckley N.A. Pharmacokinetic considerations in clinical toxicology: clinical applications. Clin Pharmacokinet. 2007;46(11):897-939. https://doi.org/10.2165/00003088-200746110-00001
  • Chan B.S., Buckley N.A. Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clin Toxicol (Phila). 2014;52(8):824-836. https://doi.org/10.3109/15563650.2014.943907
  • Vodoevich V.P., Maksimov A.I., Pashkovskij A.R., Snitko V.N. Two cases of complete drug-induced atrioventricular block. Medical business: scientific and practical therapeutic journal. 2017;3(55):68-70 (in Russ).
  • Bandara V., Weinstein S. A., White J., Eddleston M. A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning. Toxicon. 2010;56(3):273-281. https://doi.org/10.1016Zj.toxicon.2010.03.026
  • Roberts D.M., Gallapatthy G., Dunuwille A., Chan B.S. Pharmacological treatment of cardiac glycoside poisoning. Br J Clin Pharmacol. 2016;81(3):488-495. https://doi.org/10.1111/bcp.12814
  • Bismuth C., Gaultier M., Conso F., Efthymiou M.L. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6(2):153-162. https://doi.org/10.3109/15563657308990513
  • Dasgupta A., Datta P. Rapid detection of oleander poisoning using digoxin immunoassays: comparison of five assays. Ther Drug Monit. 2004;26(6):658-663. https://doi.org/10.1097/00007691-200412000-00012
  • Min J.S., Kim J., Kim J.H., Kim D., Zheng Y.F., Park J.E., Lee W., Bae S.K. Quantitative determination of arenobufagin in rat plasma by ultra fast liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study. J Pharm Biomed Anal. 2013;15(939):86-91. https://doi.org/10.1016/j.jpba.2017.08.048
  • Omidfar K., Kia S., Kashanian S., Paknejad M., Besharatie A., Kashanian S., Larijani B. Colloidal nanogold-based immunochromatographic strip test for the detection of digoxin toxicity. Applied Biochemistry and Biotechnology. 2010;160(3):843-855. https://doi.org/10.1007/s12010-009-8535-x
  • Payne V.W., Secter R.A., Noback R.K. Use of colestipol in a patient with digoxin intoxication. Drug Intell Clin Pharm. 1981;15(11):902-903. https://doi.org/10.1177/106002808101501109
  • Caldwell J.H., Greenberger N.J. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication. J Clin Invest. 1971;50(12):2626-2637. https://doi.org/10.1172/JCI106763
  • Gilfrich H.J., Okonek S., Manns M., Schuster C.J. Digoxin and digitoxin elimination in man by charcoal hemoperfusion. Klin Wochenschr. 1978;56 (23):1179-1183. https://doi.org/10.1007/bf01476862
  • Mowry J.B, Burdmann A.E., Anseeuw K., Ayoub P., Ghannoum M., Hoffman R.S., Lavergne V., Nolin T.D., Gosselin S., the EXTRIP Workgroup. Extracorporeal treatment for digoxin poisoning: systematic review and recommendations from the EXTRIP Workgroup, Clinical Toxicology. 2016;54(2):103-114. https://doi.org/10.3109/15563650.2015.1118488
  • Roberts D.M., Buckley N. Antidotes for acute cardenolide (cardiac glycoside) poisoning. Cochrane Database of Systematic Reviews. 2006; 4 Art. No.: CD005490. https://doi.org/10.1002/14651858.CD005490.pub2
  • de Silva H.A., Fonseka M.M., Pathmeswaran A., Alahakone D.G., Ratnatilake G.A., Gunatilake S.B., Rana-sinha C.D., Lalloo D.G., Aronson J.K., de Silva H.J. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet. 2003;361(9373):1935-1938. https://doi.org/10.1016/s0140-6736(03)13581-7
  • Eddleston M., Juszczak E., Buckley N.A., Senarathna L., Mohamed F., Sheriff M.H.S., Warrell D.A. Randomised controlled trial of routine single or multiple dose superactivated charcoal for self-poisoning in a region with high mortality. Clinical Toxicology 2005;43:442-443.
  • Eddleston M., Rajapakse S., Rajakanthan S., Sjöström L., Santharaj W., Thenabadu P.N., Sheriff M.H.R., Warrell D.A. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet. 2000;355(9208):967-972. https://doi.org/10.1016/s0140-6736(00)90014-x
  • Antman E.M., Wenger T.L., Butler V.P. Jr., Haber E., Smith T.W. Treatment of 150 cases of lifethreatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation. 1990;81 (6):1744-1752. https://doi.org/10.1161/01.cir.81.6.1744
  • Felicilda-Reynaldo R.F. Cardiac glycosides, digoxin toxicity, and the antidote. Medsurg Nurs. 2013;22(4): 258-261.
  • Hickey A.R., Wenger T.L., Carpenter V.P., Tilson H.H., Hlatky M.A., Furberg C.D., Kirkpatrick C.H., Strauss H.C., Smith T.W. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. Journal of the American College of Cardiology. 1991;17(3): 590-598. https://doi.org/10.1016/s0735-1097(10)80170-6
  • Ujhelyi M.R., Robert S. Pharmacokinetic aspects of digoxin-specific fab therapy in the management of digitalis toxicity. Clin Pharmacokinet. 1995;28(6):483-493. https://doi.org/10.2165/00003088-199528060-00006
  • Hursting M.J., Raisys V.A., Opheim K.E., Bell J.L., Trobaugh G.B., Smith T.W. Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose. Clin Chem. 1987;33(9):1652-1655.
  • FDA-approved labeling information: Digoxin Immune Fab (Ovine) (DigiFab), 2001 (revised in 2018). https://www.fda.gov/media/74693/
  • Hoffman R.S., Howland M., Levin N.A., Nelson L.S., Goldfrank L.R. Goldfrank's Toxicologic Emergencies, 10th edition. New York: McGraw-Hill Education, 2014:1904. ISSN 978-0071801843
  • Bracken L.M., Chan B.S.H., Buckley N.A. Physiologically based pharmacokinetic modelling of acute digoxin toxicity and the effect of digoxinspecific antibody fragments. Clinical Toxicology. 2019;57(2):117-124. https://doi.org/10.1080/15563650.2018.1503288
  • Wessler D.J., Grip L.T., Mendell J., Giugliano R.P. The P-Glycoprotein Transport System and Cardiovascular Drugs. JACC. 2013;61(25):2495-2502. https://doi.org/10.1016/j.jacc.2013.02.058
  • Schaffer S., Kim H.W. Effects and Mechanisms of Taurine as a Therapeutic Agent. Biomol Ther (Seoul). 2018;26(3):225-241. https://doi.org/10.4062/biomolther.2017.251
  • Ma H., Jiang, J., Zhang J., Zhou J., Ding A., Lv G., Duan, J. Protective effect of taurine on cardiotoxicity of the bufadienolides derived from toad (Bufo bufo gargarizans Canto) venom in guinea-pigs in vivo and in vitro. Toxicology Mechanisms and Methods. 2011:22(1):1-8. https://doi.org/10.3109/15376516.2011.583295
  • Satoh H. Cardiac actions of taurine as a modulator of the ion channels. Adv Exp Med Biol. 1998;442:121-128. https://doi.org/10.1007/978-1-4899-0117-0_16
  • Pincus M. Management of digoxin toxicity. Aust Prescr. 2016;39(1):18-20. https://doi.org/10.18773/austprescr.2016.006
  • Shulkin A.V., Yakusheva E.N., Popova N.M. The role of P-glycoprotein in rational pharmacotherapy in cardiology. Ration Pharmacother Cardiol. 2013;9(6):701-707. https://doi.org/10.20996/1819-6446-2013-9-6-701-707
  • Nola G.T., Pope S., Harrison D.C. Assessment of the synergistic relationship between serum calcium and digitalis. Am Heart J. 1970;79(4):499-507. https://doi.org/10.1016/0002-8703(70)90255-3
  • Levine M., Nikkanen H., Pallin D.J. The effects of intravenous calcium in patients with digoxin toxicity. J Emerg Med. 2011;40(1):41-46. https://doi.org/10.1016/j.jemermed.2008.09.027
  • Van Deusen S.K., Birkhahn R.H., Gaeta T.J. Treatment of hyperkalemia in a patient with unrecognized digitalis toxicity. J Clin Toxicol. 2003;41 (4):377-379. https://doi.org/10.1081/clt-120022006
  • Hack J.B., Woody J.H., Lewis D.E., Brewer K., Meggs W.J. The effect of calcium chloride in treating hyperkalemia due to acute digoxin toxicity in a porcine model. J Toxicol Clin Toxicol. 2004;42(4):337-342. https://doi.org/10.1081/clt-120039538
  • Oubaassine R., Bilbault P., Roegel J.C., Alexandre E., Sigrist S., Lavaux T., Jaeger A., Pinget M., Kessler L. Cardio protective effect of glucose-insulin infusion on acute digoxin toxicity in rat. Toxicology. 2006;224(3): 238-243. https://doi.org/10.1016Zj.tox.2006.04.035
Еще
Статья научная
SciUp 2024 © 2024 ©